Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Tmunity

Tmunity
2015 FOUNDED
PRIVATE STATUS
41-50 EMPLOYEES
Series B LATEST DEAL TYPE
$75M LATEST DEAL AMOUNT
12 INVESTORS
Description

Operator of a clinical-stage biotherapeutics company intended to develop and deliver next-generation T cell immunotherapy to patients with devastating diseases. The company's product mainly includes a novel T Cell receptor that exhibits control over T cell activation and direction as well as proprietary technologies to activate, expand, and genetically engineer T cells from peripheral blood, cord blood and tumors, enabling physicians to progress in treatment of oncology, infectious diseases and autoimmune diseases.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 3020 Market Street
  • Suite 535
  • Philadelphia, PA 19104
  • United States

+1 (215) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Tmunity’s full profile, request a free trial.

Tmunity Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 30-Oct-2019 $75M 00000 00000 Completed Startup
2. Early Stage VC (Series A) 01-Apr-2018 00000 00000 00000 Completed Startup
1. Seed Round 12-Jan-2016 $10M $10M 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Tmunity Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 1,968,007 $0.000100 6% $4.41 $4.41 1x $4.41 4.78%
To view this company’s complete Cap Table, request access »

Tmunity Competitors (34)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytImmune Venture Capital-Backed Rockville, MD 000.00 0000000000 0 000.00
00000000 Formerly VC-backed Munich, Germany 000.00 000000&0 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
0000000000 Venture Capital-Backed Abingdon, United Kingdom 000 00000 00000000000 00000
00000000000 Angel-Backed Culver City, CA 00000 000000000000 00000
To view this company’s complete list of competitors, request access »

Tmunity Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
American Cancer Society Corporation Minority 000 0000 000000 0
Andreessen Horowitz Venture Capital Minority 000 0000 000000 0
Westlake Village BioPartners Venture Capital Minority 000 0000 000000 0
Be The Match Corporation Minority 000 0000 000000 0
Gilead Sciences Corporation Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Tmunity Executive Team (12)

Name Title Board
Seat
Contact
Info
Anne Chew Ph.D Co-Founder, Advisor & Board Member
Usman Azam MD President, Chief Executive Officer & Board Member
Graeme Bell Chief Financial Officer & Executive Vice President
Jason Krentz Chief Technology Officer & Head, Technical Operations
Michael Christiano Executive Vice President and Chief Business Officer
You’re viewing 5 of 12 executives. Get the full list »

Tmunity Board Members (4)

Name Representing Role Since Contact
Info
Anne Chew Ph.D Tmunity Co-Founder, Advisor & Board Member 000 0000
Garry Nicholson Tmunity Board Member 000 0000
Patrick Gray Self Board Member 000 0000
Usman Azam MD Tmunity President, Chief Executive Officer & Board Member 000 0000